GLSI

Greenwich LifeSciences, Inc.

31.86

USD

GLSI Earnings Reports

Positive Surprise Ratio

GLSI beat 11 of 18 last estimates.

61%

Next Report

Date of Next Report

Apr 13, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.32

Implied change from Q3 25 (Revenue/ EPS)

+6.67%

Implied change from Q4 24 (Revenue/ EPS)

-47.54%

Greenwich LifeSciences, Inc. earnings per share and revenue

On Nov 14, 2025, GLSI reported earnings of -0.30 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 0.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.08% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach -- USD, implying an increase of 6.67% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

FAQ

What were Greenwich LifeSciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Greenwich LifeSciences, Inc. reported EPS of -$0.30, missing estimates by 0.3%, and revenue of $0.00, 0% as expectations.

How did the market react to Greenwich LifeSciences, Inc.'s Q3 2025 earnings?

The stock price moved down -1.08%, changed from $8.32 before the earnings release to $8.23 the day after.

When is Greenwich LifeSciences, Inc. expected to report next?

The next earning report is scheduled for Apr 13, 2026.

What are the forecasts for Greenwich LifeSciences, Inc.'s next earnings report?

Based on 3 analysts, Greenwich LifeSciences, Inc. is expected to report EPS of -$0.32 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.